Retraction notice: Retraction notice to “Growth factors and beta cell replication” (International Journal of Biochemistry and Cell Biology (2007) 39(11) (2049–2062), (S1357272507001768), (10.1016/j.biocel.2007.05.023));siRNA targeted against matrix metalloproteinase 11 inhibits the metastatic capability of murine hepatocarcinoma cell Hca-F to lymph nodes

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 11, 2007, Pages 2049-2062

  Jia, Li ^a   Wang, Shujing ^a   Cao, Jun ^a   Zhou, Huimin ^a   Wei, Wei ^a   Zhang, Jianing ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocarcinoma; Lymphatic metastasis; MMP 11; RNAi

Indexed keywords

PROTEINASE; SMALL INTERFERING RNA; STROMELYSIN 3; UNCLASSIFIED DRUG; ZINC ENDOPEPTIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RNA INTERFERENCE;

MURINAE;

EID: 34548444272     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2021.106075     Document Type: Erratum

References (39)

1. Andarawewa K.L., Boulay A., Masson R., Mathelin C., Stoll I., Tomasetto C., et al. Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression. Cancer Res. 15 (2003) 5844-5849
2. Andarawewa K.L., Motrescu E.R., Chenard M.P., Gansmuller A., Stoll I., Tomasetto C., et al. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res. 1 (2005) 10862-10871
3. Anglard P., Melot T., Guerin E., Thomas G., and Basset P. Structure and promoter characterization of the human stromelysin-3 gene. J. Biol. Chem. 270 (1995) 20337-20344
4. Basset P., Bellocq J.P., Wolf C., Stoll I., Hutin P., Limacher J.M., et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348 (1990) 699-704
5. Boulay A., Masson R., Chenard M.P., Fahime M., Cassard L., Bellocq J.P., et al. High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase. Cancer Res. 61 (2001) 2189-2193
6. Carette J.E., Overmeer R.M., Schagen F.H., Alemany R., Barski O.A., Gerritsen W.R., et al. Conditionally replicating adenoviruses expressing short hairpin RNAs silence the expression of a target gene in cancer cells. Cancer Res. 64 (2004) 2663-2667
7. Chen S., Kawashima H., Lowe J.B., Lanier L.L., and Fukuda M. Suppression of tumor formation in lymph nodes by l-selectin-mediated natural killer cell recruitment. J. Exp. Med. 202 (2005) 1679-1689
8. Chikako O., and Shinji I. Expression of stromelysin-3 (matrix metalloproteinase-11) in macrophages of murine thymus following thymocyte apoptosis. Cell. Immunol. 235 (2005) 21-28
9. Chu H., Zhou H., Liu Y., Hu Y., and Zhang J. Functional expression of CXC chemokine recepter-4 mediates the secretion of matrix metalloproteinases from mouse hepatocarcinoma cell lines with different lymphatic metastasis ability. IJBCB 39 (2007) 197-205
10. Delebecq T.J., Porte H., Zerimech F., Copin M.C., Gouyer V., Dacquembronne E., et al. Overexpression level of stromelysin 3 is related to the lymph node involvement in nonsmall cell lung cancer. Clin. Cancer Res. 6 (2000) 1086-1092
11. Deng H., Guo R.F., Li W.M., Zhao M., and Lu Y.Y. Matrix metalloproteinase 11 depletion inhibits cell proliferation in gastric cancer cells. BBRC 14 (2005) 274-281
12. Fromigue O., Louis K., Wu E., Loubat A., Shipp M., Auberger P., et al. Active stromelysin-3 (MMP-11) increases MCF-7 survival in three-dimensional Matrigel culture via activation of p42/p44 MAP-kinase. Int. J. Cancer 106 (2003) 355-363
13. Guelaguetza V.O., Patricia P.S., Karla V., Alfonso D., Lucia T., Patricia M., et al. Overexpression of cathepsin f, matrix metalloproteinases 11 and 12 in cervical cancer. BMC Cancer 5 (2005) 68
14. Hou L., Li Y., Jia Y.H., Wang B., Xin Y., Ling M.Y., et al. Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells in mice. World J. Gastroenterol. 7 (2001) 532-536
15. Illemann M., Bird N., Majeed A., Sehested M., Laerum O.D., Lund L.R., et al. MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases. Mol. Cancer Res. 4 (2006) 293-302
16. Jia L., Wang S., Zhou H., Cao J., Hu Y., and Zhang J. Caveolin-1 upregulates CD147 glycosylation and the invasive capability of murine hepatocarcinoma cell lines. IJBCB 38 (2006) 1584-1593
17. Jia L., Zhou H., Wang S., Cao J., Wei W., and Zhang J. Deglycosylation of CD147 down-regulates Matrix Metalloproteinase-11 expression and the adhesive capability of murine Hepatocarcinoma cell HcaF in vitro. IUBMB Life 58 (2006) 209-216
18. Kwak H.J., Park M.J., Cho H., Park C.M., Moon S.I., Lee H.C., et al. Transforming growth factor-B1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells. Mol. Cancer Res. 4 (2006) 209-220
19. Lepidi S., Kenagy R.D., Raines E.W., Chiu E.S., Chait A., Ross R., et al. MMP9 production by human monocytederived macrophages is decreased on polymerized type I collagen. J. Vasc. Surg. 34 (2001) 1111-1118
20. Li J., Liang V.C.T., Sedgwick T., Wong J., and Shi Y.B. Unique organization and involvement of GAGA factors in the transcriptional regulation of the Xenopus stromelysin-3 gene. Nucl. Acids Res. 26 (1998) 3018-3025
21. Liu Z., Ivanoff A., and Klominek J. Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines. Int. J. Cancer 91 (2001) 638-643
22. Ludwig M.G., Basset P., and Anglard P. Multiple regulator elements in the murine stromelysin-3 promoter: Evidence for direct control by CCAAT/enhancer-binding protein beta and thyroid and retinoid receptors. J. Biol. Chem. 275 (2000) 39981-39990
23. Manes S., Mira E., Barbacid M.M., Cipres A., FernandezResa P., Buesa J.M., et al. Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J. Biol. Chem. 272 (1997) 25706-25712
24. Masson R., Lefebvre O., Noel A., Fahime M.E., Chenard M.P., Wendling C., et al. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J. Cell Biol. 140 (1998) 1535-1541
25. Nelson A.R., Fingleton B., Rothenberg M.L., and Matrisian L.M. Matrix metalloproteinases: Biologic activity and clinical implications. J. Clin. Oncol. 18 (2000) 1135-1149
26. Noel A., Lefebvre O., Maquoi E., VanHoorde L., Chenard M.P., Mareel M., et al. Stromelysin-3 expression promotes tumor take in nude mice. J. Clin. Inves. 15 (1996) 1924-1930
27. Noel A., Boulay A., Kebers F., Kannan R., Hajitou A., and CalbergBacq C.M. Demonstration in vivo that stromelysin-3 functions through its proteolytic activity. Oncogene 19 (2000) 1605-1612
28. Pei D., Majmudar G., and Weiss S.J. Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J. Biol. Chem. 269 (1994) 25849-25855
29. Pei D., and WeissF S.J. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375 (1995) 244-247
30. Perret A.G., Duthel R., Fotso M.J., Brunon J., and Mosnier J.F. Stromelysin-3 is expressed by aggressive meningiomas. Cancer 94 (2002) 765-772
31. Rio M.C. From a unique cell to metastasis is a long way to go: Clues to stromelysin-3 participation. Biochimie 87 (2005) 299-306
32. Rouyer N., Wolf C., Chenard M.P., Rio M., Chabon P., Belloq J., et al. Stromelysin-3 gene expression in human cancer: An overview. Invasion Metastasis 95 (1994) 41269-41275
33. Sijen T., and Plasterk R.H. Transposon silencing in the Caenorhabditis elegans germ line by natural RNAi. Nature 426 (2003) 310-314
34. Von-Marschall Z., Riecken E.O., and Rosewicz S. Stromelysin 3 is overexpressed in human pancreatic carcinoma and regulated by retinoic acid in pancreatic carcinoma cell lines. Gut 43 (1998) 692-698
35. Wolf C., Rouyer N., Lutz Y., Adida C., Loriot M., Bellocq J.P., et al. Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 90 (1993) 1843-1847
36. Wu E., Mari B.P., Wang F., Anderson I.C., Sunday M.E., and Shipp M.A. Stromelysin-3 suppresses tumor cell apoptosis in a murine model. J. Cell. Biochem. 82 (2001) 549-555
37. Yi T., Marian T., Nakada K., Prabakaran K., Francis M.C., Hillary M., et al. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res. 65 (2005) 3139-3199
38. Zhang D., Salto-Tellez M., Putti T.C., Do E., and Koay E.S. Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer. Mod. Pathol. 16 (2003) 79-84
39. Zhou H., Jia L., Wang S., Wang H., Chou H., Hu Y., et al. Divergent expression and roles for caveolin-1 in mouse hepatocarcinoma cell lines with varying invasive ability. BBRC 345 (2006) 486-494